Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

South Korea · Delayed Price · Currency is KRW

63,800

-500 (-0.78%)

Aug 20, 2026, 3:30 PM KST

Mezzion Pharma Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	7,972	7,910	8,612	31,721	30,726	26,654
Revenue Growth	-5.18%	-8.15%	-72.85%	3.24%	15.28%	-6.92%
Gross Profit	1,380	1,381	1,910	3,884	-313.44	3,698
Operating Income	-17,885	-16,840	-14,300	-14,489	-23,331	-16,798
Net Income	-36,928	-34,929	-19,477	-12,728	-36,298	-13,603
Earnings Per Share	-1222.89	-1159.66	-653.00	-451.00	-1358.00	-510.00
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	17,419	25,574	28,617	58,246	32,399	47,494
Total Debt	12,421	11,873	1,616	2,241	1,063	4,321
Net Cash (Debt)	4,998	13,701	27,001	56,006	31,336	43,173
Net Cash Growth	-74.50%	-49.26%	-51.79%	78.73%	-27.42%	-1.88%
Net Cash Per Share	165.52	454.88	905.27	1983.28	1172.20	1617.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-18,952	-16,588	-18,489	-11,023	-12,075	-15,071
Capital Expenditures	-60.97	-137.39	-590.49	-529.29	-767.56	-357.81
Free Cash Flow	-19,013	-16,725	-19,080	-11,553	-12,842	-15,429
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	17.31%	17.46%	22.18%	12.25%	-1.02%	13.88%
Operating Margin	-224.35%	-212.91%	-166.05%	-45.67%	-75.93%	-63.02%
Pretax Margin	-512.26%	-491.02%	-168.77%	-39.34%	-116.87%	-48.87%
Profit Margin	-463.23%	-441.61%	-226.17%	-40.13%	-118.13%	-51.03%
FCF Margin	-238.51%	-211.46%	-221.56%	-36.42%	-41.80%	-57.89%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	71.28	71.28	71.28	71.28	71.28
PS Ratio	244.95	345.89	107.34	36.38	11.31	72.49